These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30767193)

  • 21. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
    Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
    Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KCND2 upregulation might be an independent indicator of poor survival in gastric cancer.
    Wei H; Li Y; Du Y; Ma J
    Future Oncol; 2018 Nov; 14(27):2811-2820. PubMed ID: 30051729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
    J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.
    Jiang M; Qi L; Jin K; Li L; Wu Y; Song D; Gan J; Huang M; Li Y; Song C
    Pathol Res Pract; 2021 Sep; 225():153568. PubMed ID: 34352439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
    Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
    Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
    Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer.
    Hur K; Han TS; Jung EJ; Yu J; Lee HJ; Kim WH; Goel A; Yang HK
    J Pathol; 2012 Sep; 228(1):88-98. PubMed ID: 22653794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
    Xu J; Zhou Y; Yang J; Gu Y; Zhang E; Yuan W; Wang C; Jin G; Ma H; Hu Z
    Gene; 2022 Mar; 813():146115. PubMed ID: 34902508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HAVCR1 expression might be a novel prognostic factor for gastric cancer.
    Liu L; Song Z; Zhao Y; Li C; Wei H; Ma J; Du Y
    PLoS One; 2018; 13(11):e0206423. PubMed ID: 30388143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma.
    Guo W; Lv P; Liu S; Xu F; Guo Y; Shen S; Liang J; Kuang G; Dong Z
    Mol Carcinog; 2018 Jul; 57(7):854-865. PubMed ID: 29566283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatic analysis of the prognostic value and potential regulatory network of FOXF1 in papillary thyroid cancer.
    Gu Y; Hu C
    Biofactors; 2019 Nov; 45(6):902-911. PubMed ID: 31498939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
    Ren C; Chen H; Han C; Fu D; Wang D; Shen M
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.
    Chen H; Ren C; Han C; Wang D; Chen Y; Fu D
    PLoS One; 2015; 10(3):e0119384. PubMed ID: 25793394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
    Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
    Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
    Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
    Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
    Gu Y; Feng C; Liu T; Zhang B; Yang L
    PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.